Nepsis Capital Management
Latest statistics and disclosures from Nepsis's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RNR, AMD, SHOP, CB, AIG, and represent 28.34% of Nepsis's stock portfolio.
- Added to shares of these 10 stocks: UTHR (+$19M), ORCL (+$13M), VKTX (+$11M), HCAT (+$6.9M), BMY, IRM, RLI, AMAT, WBD, DVN.
- Started 2 new stock positions in VKTX, UTHR.
- Reduced shares in these 5 stocks: GOOG (-$20M), PETQ (-$20M), QCOM, GIS, DUK.
- Sold out of its position in PETQ.
- Nepsis was a net buyer of stock by $35M.
- Nepsis has $422M in assets under management (AUM), dropping by 13.76%.
- Central Index Key (CIK): 0001587643
Tip: Access up to 7 years of quarterly data
Positions held by Nepsis Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nepsis
Nepsis holds 29 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Renaissance Re Holdings Ltd Cmn (RNR) | 6.3 | $26M | +6% | 97k | 272.40 |
|
| Advanced Micro Devices (AMD) | 6.2 | $26M | +3% | 160k | 164.08 |
|
| Shopify Cl A (SHOP) | 6.1 | $26M | +4% | 323k | 80.14 |
|
| Chubb (CB) | 5.1 | $21M | +4% | 74k | 288.39 |
|
| American Intl Group Com New (AIG) | 4.7 | $20M | +2% | 268k | 73.23 |
|
| Rli (RLI) | 4.6 | $19M | +19% | 124k | 154.98 |
|
| Amgen (AMGN) | 4.6 | $19M | +6% | 60k | 322.21 |
|
| Devon Energy Corporation (DVN) | 4.5 | $19M | +10% | 487k | 39.12 |
|
| Mastercard Incorporated Cl A (MA) | 4.5 | $19M | +4% | 39k | 493.80 |
|
| United Therapeutics Corporation (UTHR) | 4.4 | $19M | NEW | 52k | 358.35 |
|
| Cava Group Ord (CAVA) | 4.3 | $18M | +4% | 148k | 123.85 |
|
| Visa Com Cl A (V) | 4.2 | $18M | +6% | 64k | 274.95 |
|
| Health Catalyst (HCAT) | 4.1 | $17M | +67% | 2.1M | 8.14 |
|
| Cigna Corp (CI) | 4.1 | $17M | +7% | 49k | 346.44 |
|
| Qualcomm (QCOM) | 4.0 | $17M | -17% | 98k | 170.05 |
|
| Cyberark Software SHS (CYBR) | 4.0 | $17M | +2% | 57k | 291.61 |
|
| Applied Materials (AMAT) | 3.9 | $17M | +20% | 82k | 202.05 |
|
| Diamondback Energy (FANG) | 3.4 | $15M | 84k | 172.40 |
|
|
| Warner Bros Discovery Com Ser A (WBD) | 3.3 | $14M | +18% | 1.7M | 8.25 |
|
| Oracle Corporation (ORCL) | 3.1 | $13M | +3087% | 77k | 170.40 |
|
| Iron Mountain (IRM) | 2.7 | $12M | +37% | 97k | 118.83 |
|
| Viking Therapeutics (VKTX) | 2.7 | $11M | NEW | 178k | 63.31 |
|
| National Health Investors (NHI) | 1.4 | $5.7M | +18% | 68k | 84.06 |
|
| Southern Company (SO) | 1.1 | $4.4M | +19% | 49k | 90.18 |
|
| General Mills (GIS) | 1.1 | $4.4M | 60k | 73.85 |
|
|
| Bristol Myers Squibb (BMY) | 0.9 | $3.7M | +1143% | 71k | 51.74 |
|
| J P Morgan Exchange Traded F Ultra Shrt Etf (JPST) | 0.5 | $2.0M | +3% | 39k | 50.74 |
|
| Duke Energy Corp Com New (DUK) | 0.4 | $1.9M | 16k | 115.30 |
|
|
| Alphabet Cap Stk Cl C (GOOG) | 0.1 | $554k | -97% | 3.3k | 167.19 |
|
Past Filings by Nepsis
SEC 13F filings are viewable for Nepsis going back to 2013
- Nepsis 2024 Q3 filed Oct. 18, 2024
- Nepsis 2024 Q2 filed July 15, 2024
- Nepsis 2024 Q1 filed April 12, 2024
- Nepsis 2023 Q4 filed Jan. 18, 2024
- Nepsis 2023 Q3 filed Oct. 13, 2023
- Nepsis 2023 Q2 filed July 18, 2023
- Nepsis 2023 Q1 filed April 14, 2023
- Nepsis 2022 Q4 filed Jan. 25, 2023
- Nepsis 2022 Q3 filed Nov. 1, 2022
- Nepsis 2022 Q2 filed Aug. 2, 2022
- Nepsis 2022 Q1 filed April 13, 2022
- Nepsis 2021 Q4 filed Jan. 14, 2022
- Nepsis 2021 Q3 filed Oct. 13, 2021
- Nepsis 2021 Q2 filed July 15, 2021
- Nepsis 2021 Q1 filed April 20, 2021
- Nepsis 2020 Q4 filed Jan. 22, 2021